Efficacy of Ritlecitinib (PF-06651600) in Patients With Alopecia Totalis and Alopecia Universalis: Post Hoc Analysis of the ALLEGRO Phase 2b 3 Study. J of Skin 2022, 6 (6), s102. https://doi.org/10.25251/skin.6.supp.102.